%E2%80%99%EC%9D%98%20%EB%8C%80%EC%8B%9C%EB%B3%B4%EB%93%9C%EB%A5%BC%20%EC%82%B4%ED%8E%B4%EB%B3%B4%EB%A9%B0%20%EC%9E%85%EC%9B%90%20%ED%99%98%EC%9E%90%EC%9D%98%20%EC%83%81%ED%83%9C%EB%A5%BC%20%ED%99%95%EC%9D%B8%ED%95%98%EA%B3%A0%20%EC%9E%88%EB%8B%A4-800x600.webp)
AI smart monitoring system established for 127 out of 204 total beds to strengthen patient safety management.
Expanding smart medical environments from specialized centers and AI diagnostics to general wards.
Seran Hospital has implemented an artificial intelligence (AI)-based monitoring system across 127 beds, establishing a framework for 24-hour surveillance of inpatient vital signs. The initiative aims to monitor patient status changes in real-time and facilitate rapid medical responses, thereby bolstering safety management in general wards.
Daewoong Pharmaceutical announced on the 13th that it has supplied its AI smart monitoring system, 'thynC,' to Seran Hospital in Jongno-gu, Seoul. By installing the system in 127 of its 204 total beds, Seran Hospital has extended the use of AI and digital technologies—previously utilized in specialized centers and health screenings—to general inpatient care.
The 'thynC' system utilizes wearable sensors attached to patients to transmit biometric data in real-time to central ward monitors and medical staff mobile devices. This allows clinicians to continuously track changes in electrocardiograms (ECG), heart rate, respiratory rate, and oxygen saturation.
Seran Hospital plans to use this technology to bridge monitoring gaps that may occur during nighttime hours or between scheduled rounds. The focus is on early detection of potential health deterioration in wards where staff must manage multiple patients, ensuring that necessary interventions are executed promptly.
The hospital expects that integrating AI-analyzed real-time biometric data with clinical judgment will reduce the risk of in-hospital emergencies and foster a more secure environment for patients and their families.
Seran Hospital currently operates specialized centers for cranial nerves, spine, artificial joints, and shoulder joints, while applying AI technology to diagnostics. Its comprehensive health screening center utilizes AI to analyze various medical data, including mammography, chest X-rays, MRI, ECG, and retinal imaging, to assist medical staff in interpretation and diagnosis.
The hospital has also implemented 'AiTiA,' a cardiac risk prediction solution, further expanding its AI application into disease risk forecasting. With the introduction of 'thynC,' the hospital has now extended its digital footprint from screening and diagnosis to continuous inpatient monitoring.
Hong Kwang-pyo, President of Seran Hospital, stated, "We are actively adopting AI and digital technologies to enhance patient safety and the quality of care. Through 'thynC,' we will strengthen our ward management system and create a safer medical environment."
Park Hyung-chul, Head of the ETC Marketing Division at Daewoong Pharmaceutical, added, "Seran Hospital is accelerating the construction of a smart medical environment by actively adopting various AI and digital medical technologies. We will continue to cooperate to ensure that 'thynC' contributes to patient safety and efficient ward operations."
